Changde Zhang

955 total citations
27 papers, 781 citations indexed

About

Changde Zhang is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Changde Zhang has authored 27 papers receiving a total of 781 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Organic Chemistry and 8 papers in Oncology. Recurrent topics in Changde Zhang's work include Estrogen and related hormone effects (7 papers), Histone Deacetylase Inhibitors Research (5 papers) and Chemical Synthesis and Analysis (3 papers). Changde Zhang is often cited by papers focused on Estrogen and related hormone effects (7 papers), Histone Deacetylase Inhibitors Research (5 papers) and Chemical Synthesis and Analysis (3 papers). Changde Zhang collaborates with scholars based in United States, China and Germany. Changde Zhang's co-authors include Guangdi Wang, Shilong Zheng, Qiu Zhong, Nicolás G. Bazán, Shanchun Guo, Loren Price, William H. Daly, Qiang Zhang, Madhusoodanan Mottamal and Kristal D. Atkins and has published in prestigious journals such as PLoS ONE, Analytical Chemistry and Journal of Medicinal Chemistry.

In The Last Decade

Changde Zhang

25 papers receiving 771 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Changde Zhang United States 15 289 261 127 112 93 27 781
Eli Oldham United States 2 452 1.6× 96 0.4× 119 0.9× 57 0.5× 67 0.7× 7 757
Beata Filip‐Psurska Poland 17 210 0.7× 125 0.5× 209 1.6× 75 0.7× 61 0.7× 44 734
Peter Geiger United States 14 477 1.7× 82 0.3× 185 1.5× 105 0.9× 37 0.4× 30 969
Simran S. Sabharwal United States 5 930 3.2× 146 0.6× 197 1.6× 61 0.5× 42 0.5× 8 1.6k
Wenliang Chen China 20 594 2.1× 250 1.0× 60 0.5× 55 0.5× 76 0.8× 47 1.2k
Asma M. Aman Canada 20 693 2.4× 196 0.8× 238 1.9× 31 0.3× 66 0.7× 45 1.5k
Jianhui Wu China 17 724 2.5× 314 1.2× 133 1.0× 28 0.3× 41 0.4× 102 1.3k
Fahui Li China 17 648 2.2× 152 0.6× 95 0.7× 32 0.3× 35 0.4× 45 1.1k
Steven H. Olson United States 24 669 2.3× 545 2.1× 179 1.4× 45 0.4× 44 0.5× 47 1.7k
Samit K. Bhattacharya United States 17 269 0.9× 353 1.4× 153 1.2× 62 0.6× 19 0.2× 29 803

Countries citing papers authored by Changde Zhang

Since Specialization
Citations

This map shows the geographic impact of Changde Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changde Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changde Zhang more than expected).

Fields of papers citing papers by Changde Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changde Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changde Zhang. The network helps show where Changde Zhang may publish in the future.

Co-authorship network of co-authors of Changde Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Changde Zhang. A scholar is included among the top collaborators of Changde Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changde Zhang. Changde Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Shanchun, Shilong Zheng, Changde Zhang, et al.. (2024). Discovery of Oral Degraders of the ROS1 Fusion Protein with Potent Activity against Secondary Resistance Mutations. Journal of Medicinal Chemistry. 67(20). 18098–18123.
2.
Mottamal, Madhusoodanan, Qiu Zhong, Melyssa R. Bratton, et al.. (2023). Design, Synthesis, and Evaluation of Niclosamide Analogs as Therapeutic Agents for Enzalutamide-Resistant Prostate Cancer. Pharmaceuticals. 16(5). 735–735. 6 indexed citations
3.
Ma, Peng, et al.. (2021). Estrogen Activity of OTC Topical Medications Containing Parabens Depends on Paraben Type and Concentration. Journal of the Endocrine Society. 5(Supplement_1). A486–A487.
4.
Ma, Peng, et al.. (2021). Bisacodyl in Stimulant Laxatives Can Induce Estrogen Agonist/Antagonist Activity in Breast Cancer Cells in Culture. Journal of the Endocrine Society. 5(Supplement_1). A483–A483. 1 indexed citations
5.
Guo, Shanchun, et al.. (2020). GLL398, an oral selective estrogen receptor degrader (SERD), blocks tumor growth in xenograft breast cancer models. Breast Cancer Research and Treatment. 180(2). 359–368. 10 indexed citations
6.
Luo, Lan, Qiu Zhong, Shanchun Guo, et al.. (2020). Development of a bioavailable boron-containing PI-103 Bioisostere, PI-103BE. Bioorganic & Medicinal Chemistry Letters. 30(14). 127258–127258. 14 indexed citations
7.
Zheng, Shilong, Shanchun Guo, Qiu Zhong, et al.. (2018). Biocompatible Boron-Containing Prodrugs of Belinostat for the Potential Treatment of Solid Tumors. ACS Medicinal Chemistry Letters. 9(2). 149–154. 30 indexed citations
8.
Zhang, Changde, Guanglin Chen, Shanchun Guo, et al.. (2018). Optimization of diarylpentadienones as chemotherapeutics for prostate cancer. Bioorganic & Medicinal Chemistry. 26(16). 4751–4760. 5 indexed citations
9.
Li, Xiang, Changde Zhang, Shanchun Guo, et al.. (2018). Structure-activity relationship and pharmacokinetic studies of 3-O-substitutedflavonols as anti-prostate cancer agents. European Journal of Medicinal Chemistry. 157. 978–993. 9 indexed citations
10.
Guo, Shanchun, Changde Zhang, Melyssa R. Bratton, et al.. (2018). ZB716, a steroidal selective estrogen receptor degrader (SERD), is orally efficacious in blocking tumor growth in mouse xenograft models. Oncotarget. 9(6). 6924–6937. 28 indexed citations
11.
Zhang, Xiaojie, Shanchun Guo, Chengsheng Chen, et al.. (2017). Asymmetric 1,5-diarylpenta-1,4-dien-3-ones: Antiproliferative activity in prostate epithelial cell models and pharmacokinetic studies. European Journal of Medicinal Chemistry. 137. 263–279. 10 indexed citations
12.
Zhang, Changde, Shanchun Guo, Lin Yang, et al.. (2017). Metabolism, pharmacokinetics, and bioavailability of ZB716, a Steroidal Selective Estrogen Receptor Downregulator (SERD). Oncotarget. 8(61). 103874–103889. 17 indexed citations
13.
Liu, Jiawang, Shilong Zheng, Shanchun Guo, et al.. (2016). Rational Design of a Boron-Modified Triphenylethylene (GLL398) as an Oral Selective Estrogen Receptor Downregulator. ACS Medicinal Chemistry Letters. 8(1). 102–106. 29 indexed citations
14.
Cunningham, David, Keshab R. Parajuli, Changde Zhang, et al.. (2016). Monomethyl Auristatin E Phosphate Inhibits Human Prostate Cancer Growth. The Prostate. 76(15). 1420–1430. 19 indexed citations
15.
Zhong, Qiu, Changde Zhang, Qiang Zhang, et al.. (2015). Boronic prodrug of 4-hydroxytamoxifen is more efficacious than tamoxifen with enhanced bioavailability independent of CYP2D6 status. BMC Cancer. 15(1). 625–625. 31 indexed citations
16.
Zhang, Changde, Qiu Zhong, Qıang Zhang, et al.. (2015). Boronic prodrug of endoxifen as an effective hormone therapy for breast cancer. Breast Cancer Research and Treatment. 152(2). 283–291. 31 indexed citations
17.
Wang, Rubing, Chengsheng Chen, Xiaojie Zhang, et al.. (2015). Structure–Activity Relationship and Pharmacokinetic Studies of 1,5-Diheteroarylpenta-1,4-dien-3-ones: A Class of Promising Curcumin-Based Anticancer Agents. Journal of Medicinal Chemistry. 58(11). 4713–4726. 47 indexed citations
18.
Eady, Tiffany N., Ludmila Belayev, Larissa Khoutorova, et al.. (2012). Docosahexaenoic Acid Signaling Modulates Cell Survival in Experimental Ischemic Stroke Penumbra and Initiates Long-Term Repair in Young and Aged Rats. PLoS ONE. 7(10). e46151–e46151. 69 indexed citations
19.
Bazán, Nicolás G., Tiffany N. Eady, Larissa Khoutorova, et al.. (2012). Novel aspirin-triggered neuroprotectin D1 attenuates cerebral ischemic injury after experimental stroke. Experimental Neurology. 236(1). 122–130. 89 indexed citations
20.
Zhang, Changde & Nicolás G. Bazán. (2010). Lipid-Mediated Cell Signaling Protects against Injury and Neurodegeneration. Journal of Nutrition. 140(4). 858–863. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eli Oldham Breakdown of academic impact, for papers by Beata Filip‐Psurska Breakdown of academic impact, for papers by Peter Geiger Breakdown of academic impact, for papers by Simran S. Sabharwal Breakdown of academic impact, for papers by Wenliang Chen Breakdown of academic impact, for papers by Asma M. Aman Breakdown of academic impact, for papers by Jianhui Wu Breakdown of academic impact, for papers by Fahui Li Breakdown of academic impact, for papers by Steven H. Olson Breakdown of academic impact, for papers by Samit K. Bhattacharya
Rankless by CCL
2026